angiotensin ii has been researched along with mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beretz, A; Etienne-Selloum, N; Kane, MO; Sarr, M; Schini-Kerth, VB; Walter, A | 1 |
1 other study(ies) available for angiotensin ii and mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin
| Article | Year |
|---|---|
Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenols.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Blotting, Western; Disease Models, Animal; Enzyme Inhibitors; Flavonoids; Fluorescent Antibody Technique; Hypertension; Male; Matrix Metalloproteinase 2; Metalloporphyrins; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroarginine; Peroxynitrous Acid; Phenols; Polyphenols; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A; Wine | 2008 |